BioLingus ^None

BioLingus is a biotech company based in Switzerland that specializes in developing oral and mucosal delivery of peptides and proteins. They use applied bio-engineering to create bio-mimetic materials for oral formulations of various substances, including hydrophobic small molecules. The company focuses on developing products for chronic diseases like diabetes and inflammatory diseases, with a particular interest in oral immunotherapy. BioLingus has a satellite company in Hong Kong.